OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Matrix Metalloproteinases as Potential Biomarkers and Therapeutic Targets in Liver Diseases
Eline Geervliet, Ruchi Bansal
Cells (2020) Vol. 9, Iss. 5, pp. 1212-1212
Open Access | Times Cited: 131

Showing 26-50 of 131 citing articles:

Vasomics of the liver
Chengyan Wang, Éric Felli, Jonathan A. Fallowfield, et al.
Gut (2025), pp. gutjnl-334133
Closed Access

Evaluating the role of targeted silymarin loaded hyaluronic acid/protein nanoparticles in activating hepatic progenitor stem cells for liver regeneration after CCl4-induced liver damage
Rawan O El-Belkasy, Maged El‐Kemary, Nemany A.N. Hanafy
International Journal of Biological Macromolecules (2025), pp. 142837-142837
Closed Access

Anti-fibrotic treatments for chronic liver diseases: The present and the future
Naoshi Odagiri, Tsutomu Matsubara, Misako Sato, et al.
Clinical and Molecular Hepatology (2020) Vol. 27, Iss. 3, pp. 413-424
Open Access | Times Cited: 34

Recent progress in molecular mechanisms of postoperative recurrence and metastasis of hepatocellular carcinoma
Zhao-Shan Niu, Wenhong Wang, Xiao-Jun Niu
World Journal of Gastroenterology (2022) Vol. 28, Iss. 46, pp. 6433-6477
Open Access | Times Cited: 20

FXR agonists INT‐787 and OCA increase RECK and inhibit liver steatosis and inflammation in diet‐induced ob/ob mouse model of NASH
Laura Giuseppina Di Pasqua, Marta Cagna, G. Palladini, et al.
Liver International (2023) Vol. 44, Iss. 1, pp. 214-227
Open Access | Times Cited: 11

Fucoxanthin Enhances the Antifibrotic Potential of Placenta-derived Mesenchymal Stem Cells in a CCl4-induced Mouse Model of Liver
Vasilii N. Slautin, Konstantin Konyshev, I. V. Gavrilov, et al.
Current Stem Cell Research & Therapy (2024) Vol. 19, Iss. 11, pp. 1484-1496
Closed Access | Times Cited: 4

Resveratrol and its nanocrystals: A promising approach for cancer therapy?
Daniela Ančić, Nada Oršolić, Dyana Odeh, et al.
Toxicology and Applied Pharmacology (2021) Vol. 435, pp. 115851-115851
Closed Access | Times Cited: 23

Physiological Properties, Functions, and Trends in the Matrix Metalloproteinase Inhibitors in Inflammation-Mediated Human Diseases
Il-Sup Kim, Woong‐Suk Yang, Cheorl‐Ho Kim
Current Medicinal Chemistry (2022) Vol. 30, Iss. 18, pp. 2075-2112
Closed Access | Times Cited: 18

Serum matrix metalloproteinase-7 levels in infants with cholestasis and biliary atresia
Pejman Rohani, Bahador Mirrahimi, Haleh Bashirirad, et al.
BMC Pediatrics (2022) Vol. 22, Iss. 1
Open Access | Times Cited: 16

Dynamic expression of H19 and MALAT1 and their correlation with tumor progression biomarkers in a multistage hepatocarcinogenesis model
Sherien M. El‐Daly, Mona A. El‐Bana, Sahar S. Abd El‐Rahman, et al.
Cell Biochemistry and Function (2023) Vol. 41, Iss. 3, pp. 331-343
Closed Access | Times Cited: 9

In Vitro Investigation of the Anti-Fibrotic Effects of 1-Phenyl-2-Pentanol, Identified from Moringa oleifera Lam., on Hepatic Stellate Cells
Watunyoo Buakaew, Sucheewin Krobthong, Yodying Yingchutrakul, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 16, pp. 8995-8995
Open Access | Times Cited: 3

Hepatic TREM2+ macrophages express matrix metalloproteinases to control fibrotic scar formation
Kyeong‐Jin Lee, Seungchan An, Mi‐Yeon Kim, et al.
Immunology and Cell Biology (2022) Vol. 101, Iss. 3, pp. 216-230
Closed Access | Times Cited: 14

Diagnostic potential and future directions of matrix metalloproteinases as biomarkers in gingival crevicular fluid of oral and systemic diseases
Fan Zhang, Enyan Liu, Allan Radaic, et al.
International Journal of Biological Macromolecules (2021) Vol. 188, pp. 180-196
Closed Access | Times Cited: 19

Interplay between Cellular and Non-Cellular Components of the Tumour Microenvironment in Hepatocellular Carcinoma
Tamás Sükei, Elena Palma, Luca Urbani
Cancers (2021) Vol. 13, Iss. 21, pp. 5586-5586
Open Access | Times Cited: 19

The Gut Microbiota-Derived Immune Response in Chronic Liver Disease
Sung‐Min Won, Eunju Park, Jin‐Ju Jeong, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 15, pp. 8309-8309
Open Access | Times Cited: 18

Concentration of Serum Matrix Metalloproteinase-3 in Patients With Primary Biliary Cholangitis
Alicja Bauer, Andrzej Habior
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 13

Piperine as Therapeutic Agent in Paracetamol-Induced Hepatotoxicity in Mice
Aline Meireles Coelho, Isabela Ferreira Queiroz, Luíza Oliveira Perucci, et al.
Pharmaceutics (2022) Vol. 14, Iss. 9, pp. 1800-1800
Open Access | Times Cited: 13

Extracellular matrix turnover: phytochemicals target and modulate the dual role of matrix metalloproteinases (MMPs) in liver fibrosis
Usman Sabir, Hongmei Gu, Dawei Zhang
Phytotherapy Research (2023) Vol. 37, Iss. 11, pp. 4932-4962
Open Access | Times Cited: 7

The effect of hepatic stellate cell derived-IL-11 on hepatocyte injury in hepatic fibrosis
Lingfeng Jiang, Ming Yang, Hongwu Meng, et al.
Life Sciences (2023) Vol. 330, pp. 121974-121974
Closed Access | Times Cited: 7

The Role of Macrophage Inhibitory Factor in TAA-Induced Liver Fibrosis in Mice: Modulatory Effects of Betaine
Tatjana Radosavljević, Dušan Vukićević, Jasmina Djuretić, et al.
Biomedicines (2024) Vol. 12, Iss. 6, pp. 1337-1337
Open Access | Times Cited: 2

Enzymes of Fibrosis in Chronic Liver Disease
Ioannis Tsomidis, George Notas, Costas Xidakis, et al.
Biomedicines (2022) Vol. 10, Iss. 12, pp. 3179-3179
Open Access | Times Cited: 12

Scroll to top